Trial Profile
Detection of Prostate Cancer With Contrast-Enhanced Ultrasound After Treatment With Dutasteride.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Dutasteride (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- 27 Jan 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 18 Dec 2008 New trial record.